HealthTide Biotech
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from HealthTide Biotech between 17 Nov 2025 and 26 Feb 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
HealthTide Biotech
Retatrutide
Tested 5 Samples
Last test 26 Feb 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from HealthTide Biotech
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
26 Feb 2026
First
17 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 26 Feb 2026 | View | 10mg | 10.1mg | +1.0% | 99.61% | n/a | RT10 | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 22 Feb 2026 | View | 10mg | 8.97mg | -10.3% | 99.90% | below LOQ | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 15 Jan 2026 | View | 15mg | 14.8mg | -1.3% | 99.95% | n/a | (no batch ID) | Silver Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 17 Nov 2025 | View | 60mg | 55.5mg | -7.5% | 99.76% | n/a | (no batch ID) | No Label / Blue Crimp / Clear Cap | Lab E | Public | |
| 17 Nov 2025 | View | 10mg | 9.76mg | -2.4% | 99.10% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |